DEUTSCHE BANK AG\ - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 82 filers reported holding RECRO PHARMA INC in Q2 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2021$253,000
-26.2%
109,680
-10.6%
0.00%
Q1 2021$343,000
-35.2%
122,707
-33.8%
0.00%
Q4 2020$529,000
+31.9%
185,330
-2.9%
0.00%
Q3 2020$401,000
-51.9%
190,804
+4.3%
0.00%
-100.0%
Q2 2020$833,000
+101.7%
182,997
+262.3%
0.00%
Q1 2020$413,000
+120.9%
50,516
+391.3%
0.00%
Q4 2019$187,000
-62.9%
10,283
-77.4%
0.00%
Q3 2019$504,000
-10.3%
45,595
-17.6%
0.00%
Q2 2019$562,000
+322.6%
55,337
+139.4%
0.00%
Q1 2019$133,000
-17.9%
23,115
+0.6%
0.00%
Q4 2018$162,000
-69.5%
22,973
-69.4%
0.00%
Q3 2018$532,000
+50.7%
75,081
+6.7%
0.00%
Q2 2018$353,000
-61.6%
70,369
-15.8%
0.00%
Q1 2018$919,000
+227.0%
83,559
+174.4%
0.00%
Q4 2017$281,000
+150.9%
30,446
+141.6%
0.00%
Q3 2017$112,000
+0.9%
12,601
-21.0%
0.00%
Q2 2017$111,00015,942
+29979.2%
0.00%
Q1 2017$0
-100.0%
53
-99.8%
0.00%
Q3 2016$204,000
+1033.3%
23,164
+901.0%
0.00%
Q2 2016$18,000
+200.0%
2,314
+362.8%
0.00%
Q2 2015$6,0005000.00%
Other shareholders
RECRO PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders